首页> 外文期刊>Clinical and experimental allergy : >Intestinal permeability in healthy and allergic children before and after sodium‐cromoglycate treatment assessed with different‐sized polyethyleneglycols (PEG 400 and PEG 1000)
【24h】

Intestinal permeability in healthy and allergic children before and after sodium‐cromoglycate treatment assessed with different‐sized polyethyleneglycols (PEG 400 and PEG 1000)

机译:使用不同大小的聚乙二醇(PEG 400 和 PEG 1000)评估的色甘酸钠治疗前后健康和过敏儿童的肠道通透性

获取原文
获取外文期刊封面目录资料

摘要

SummaryGastrointestinal permeability was investigated in twenty‐two children on two occasions, before and after treatment with sodium cromoglycate. The children were between 8 and 10 years old; half of them were classified as allergic according to history and laboratory tests, and half of them as healthy. The 6‐hr urinary recovery of different‐sized polyethyleneglycols (PEG 400 and PEG 1000) in combination with a mathematical model was used to assess the intestinal permeability barrier.No significant differences were seen in the first PEG test between healthy and allergic children, although those with gastrointestinal allergy showed a slightly lower, and those with other allergies a slightly higher recovery of the smaller PEGs than seen in the healthy individuals. After treatment with sodium cromoglycate. however, there was a significant decrease in uptake by allergic children, which could indicate that the permeability properties had returned to normal.The PEG method offers a simple, harmless and reproducible method to measure intestinal permeability properties. The change in permeability observed after sodium cromoglycate corresponds well with the clinical experience of usefulness of the drug in some children with food al
机译:摘要对 22 名儿童进行了两次胃肠道通透性调查,分别在色甘酸钠治疗前后。这些儿童的年龄在8至10岁之间;根据病史和实验室检查,其中一半被归类为过敏,一半被归类为健康。不同大小的聚乙二醇(PEG 400 和 PEG 1000)的 6 小时尿回收率结合数学模型用于评估肠道通透性屏障。在第一次PEG测试中,健康和过敏儿童之间没有显着差异,尽管胃肠道过敏的儿童显示出略低的差异,而其他过敏儿童的较小PEG的恢复率略高于健康个体。用色甘酸钠治疗后。然而,过敏儿童的摄取量显着下降,这可能表明渗透性已恢复正常。PEG 方法提供了一种简单、无害且可重复的方法来测量肠道通透性特性。色甘酸钠后观察到的通透性变化与该药物在一些儿童中有用的临床经验非常吻合。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号